Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/05/2026 | Q4 | $52.4M | -- | -- | $0.18 | -- |
| 11/07/2025 | Q3 | $57.6M | $66M | $0.28 | $0.33 | -$0.05 |
| 08/05/2025 | Q2 | $56.6M | $55.5M | $0.42 | $0.23 | $0.18 |
| 06/09/2025 | Q1 | $55.7M | $59.3M | $0.40 | $0.19 | $0.21 |
| 02/07/2025 | Q4 | $49.5M | $47M | $0.14 | $0.08 | $0.07 |
| 11/08/2024 | Q3 | $49.7M | $53.6M | $0.30 | $0.13 | $0.17 |
| 08/07/2024 | Q2 | $50.1M | $50M | $0.27 | $0.18 | $0.09 |
| 06/07/2024 | Q1 | $44.5M | $49.1M | $0.12 | -- | -- |
| 02/05/2024 | Q4 | $38.9M | $43.8M | $0.02 | -- | -- |
| 11/06/2023 | Q3 | -- | $45.1M | $0.04 | -- | -- |
| 08/07/2023 | Q2 | -- | $47.6M | $0.25 | -- | -- |
| 06/08/2023 | Q1 | -- | $43M | -$0.05 | -- | -- |
| 02/06/2023 | Q4 | -- | $39.9M | $0.03 | -- | -- |
| 11/07/2022 | Q3 | -- | $38.1M | -$0.02 | -- | -- |
| 07/29/2022 | Q2 | -- | $36.1M | $0.06 | -- | -- |
| 06/08/2022 | Q1 | -- | $39.7M | -$0.13 | -- | -- |
| 02/07/2022 | Q4 | -- | $28.8M | -$0.35 | -- | -- |
| 10/27/2021 | Q3 | -- | $34.1M | -$0.05 | -- | -- |
| 08/10/2021 | Q2 | -- | $20.2M | -$0.31 | -- | -- |
| 06/01/2021 | Q1 | -- | $25.7M | $0.04 | -- | -- |
| 01/28/2021 | Q4 | -- | $27.2M | $0.11 | -- | -- |
| 10/28/2020 | Q3 | -- | $28M | $0.28 | -- | -- |
| 07/30/2020 | Q2 | -- | $16.7M | -$0.18 | -- | -- |
| 06/10/2020 | Q1 | -- | $23.1M | $0.06 | -- | -- |
| 01/29/2020 | Q4 | -- | $25.3M | $0.00 | -- | -- |
| 10/30/2019 | Q3 | -- | $21.6M | $0.12 | -- | -- |
| 07/26/2019 | Q2 | -- | $20.6M | $0.01 | -- | -- |
| 05/30/2019 | Q1 | -- | $23.6M | -$0.46 | -- | -- |
| 01/30/2019 | Q4 | -- | $17.2M | $0.01 | -- | -- |
| 11/08/2018 | Q3 | -- | $21.4M | $0.19 | -- | -- |
| 08/03/2018 | Q2 | -- | $29.6M | $0.24 | -- | -- |
| 05/31/2018 | Q1 | -- | $22.2M | $0.09 | -- | -- |
| 02/01/2018 | Q4 | -- | $17.3M | -$1.19 | -- | -- |
| 10/25/2017 | Q3 | -- | $17.2M | $0.00 | -- | -- |
| 08/04/2017 | Q2 | -- | $20.9M | $0.10 | -- | -- |
| 06/01/2017 | Q1 | -- | $25.6M | $0.18 | -- | -- |
| 02/01/2017 | Q4 | -- | $22.7M | $0.19 | -- | -- |
| 11/01/2016 | Q3 | -- | $21.1M | $0.13 | -- | -- |
| 07/29/2016 | Q2 | -- | $22.4M | $0.01 | -- | -- |
| 05/25/2016 | Q1 | -- | $22.3M | $0.05 | -- | -- |
| 01/29/2016 | Q4 | -- | $17.3M | $0.13 | -- | -- |
Graham Corp. reported $66M worth of top line sales in its most recent quarter.
Graham Corp. announced earnings per share of $0.28 which represents a miss of analyst forecast a $0.33 per share.
Graham Corp. reported $13.9M that represents $1.25 per share over the last quarter.
Graham Corp.'s earnings are forecast to grow from $1.11 per share to $1.00 per share next year representing an increase of 16.42%.
Graham Corp.'s next earnings date is February 5, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.